Clinilabs Drug Development Corporation is a contract research organization (CRO) that provides clinical drug development services to industry. We are experts in CNS drug development. Clinilabs provides first-in-human through end of phase 3 services, with a global core laboratory. It is an alternative to large CROs providing a full spectrum of offerings to meet the needs of our customers world wide. Since 2000, Clinilabs has completed more than 675 clinical trials, and has worked for 15 of the top 20 pharma companies in the world, to contribute to 19 successful new drug applications (NDAs).